Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations in BRCA1 associated protein 1 (BAP1) are associated with unique disease profiles in mesothelioma, atypical spitz nevi, and uveal melanoma, but the patient characteristics of an unselected population of BAP1 carriers identified by an ascertainment prevalence study are unknown.
|
31323388 |
2019 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Both UM and CM have been shown to harbor germline mutation of BAP1.
|
24697775 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Screening of BAP1 germline mutations in families predisposed for UM may be used to identify individuals at increased risk of disease.
|
23341325 |
2013 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
All BAP1 mutations identified in blood samples were also present in the matched UM.
|
30477459 |
2018 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
|
31058963 |
2019 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Uveal melanoma is a life-threatening disease for which data on germline predisposition are essentially limited to mutations in the BAP1 gene.
|
31626034 |
2020 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Whole-exome sequencing identified a BAP1 splice mutation located at c.581-2A>G, which leads to a premature truncation of BAP1 in an individual with uveal melanoma.
|
23977234 |
2013 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hence, epigenetic inhibitors are being investigated in BAP1 mutant uveal melanoma.
|
29206651 |
2018 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Current evidence demonstrates that germline BAP1 mutations predispose families to uveal melanoma, renal cell carcinoma, malignant mesothelioma, cutaneous melanoma, and possibly to a range of other cancers as well.
|
26096145 |
2016 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A targeted next-generation sequencing approach was applied, covering the mutational hotspot regions of nine genes known to be mutated in conjunctival and uveal melanoma (BRAF, NRAS, KIT, GNAQ, GNA11, CYSLTR2, SF3B1, EIF1AX, and BAP1).
|
28700778 |
2017 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
|
24970262 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Somatic BAP1 mutations are seen in cutaneous melanocytic tumours (epithelioid atypical Spitz tumours and melanoma), uveal melanoma, mesothelioma, clear cell renal cell carcinoma, and other tumours.
|
23277170 |
2013 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A cancer surveillance program for individuals who carry germline BAP1 mutations may help identify tumors such as uveal melanoma, cutaneous melanoma, and renal cell carcinoma at early and treatable stages.
|
28482042 |
2017 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Uveal melanoma (UM), a rare cancer of the eye, is characterized by initiating mutations in the genes G-protein subunit alpha Q (<i>GNAQ</i>), G-protein subunit alpha 11 (<i>GNA11</i>), cysteinyl leukotriene receptor 2 (<i>CYSLTR2</i>), and phospholipase C beta 4 (<i>PLCB4</i>) and by metastasis-promoting mutations in the genes splicing factor 3B1 (<i>SF3B1</i>), serine and arginine rich splicing factor 2 (SRSF2), and BRCA1-associated protein 1 (<i>BAP1</i>).
|
31671564 |
2019 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
BAP1 mutations are frequently found in UM and are associated with a poor prognosis.
|
25582751 |
2015 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
De-ubiquitinating enzyme BAP1 is mutated in a hereditary cancer syndrome with increased risk of mesothelioma and uveal melanoma.
|
22878500 |
2012 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Somatic mutations of BRCA1 associated protein-1 (BAP1) gene were recently found in MM as well as in uveal melanoma and kidney cancer among the Caucasian and Japanese people.
|
26246155 |
2015 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
While young patients with UM should be screened for germline BAP1 mutations, our results suggest that there is a need to identify other candidate genes which are responsible for UM in young patients.
|
25687217 |
2015 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We report the population-based frequency of germline pathogenic variants of BAP1 in Finnish patients with uveal melanoma who live in a high-risk region for this cancer.
|
26876698 |
2016 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
However, BAP1 germline mutations have been identified in rare hereditary tumour syndromes, including cases with UM.
|
24187051 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The BRCA1-associated protein-1 (BAP1) tumor predisposition syndrome (BAP1-TPDS) is a hereditary tumor syndrome caused by germline pathogenic variants in BAP1 encoding a tumor suppressor associated with uveal melanoma, mesothelioma, cutaneous melanoma, renal cell carcinoma, and cutaneous BAP1-inactivated melanocytic tumors.
|
30517737 |
2018 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Recently, the BAP1 mutation and its involvement in cancer survival have been reported in a range of tumor types, including uveal melanoma, mesothelioma, renal cancers, and biliary tract cancers.
|
30395583 |
2018 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The most prevalent malignancies among BAP1 mutation carriers were uveal melanoma (n = 60 [28%]), mesothelioma (n = 48 [22%]), cutaneous melanoma (n = 38 [18%]), and renal cell carcinoma (n = 20 [9%]).
|
28793149 |
2017 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Next generation sequencing of uveal melanoma (UM) samples has identified a number of recurrent oncogenic or loss-of-function mutations in key driver genes including: GNAQ, GNA11, EIF1AX, SF3B1 and BAP1.
|
26683228 |
2016 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Consistently, BAP1 mutation was correlated with critical clinicopathological features only in uveal melanoma and clear cell renal cell carcinoma.
|
28618948 |
2017 |